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TP53INP1 is a nuclear factor that is rapidly and strongly induced by various stresses. 
TP53INP1 is overexpressed in acinar cells during acute pancreatitis in the mouse. TP53INP1 
overexpression promotes cellular apoptosis. It is known acinar cell apoptosis is involved in 
acinar destruction/degeneration in the course of chronic pancreatitis. Therefore, examining 
TP53INP1 gene expression in CP and related to acinar cell apoptosis will contribute to a better 
understanding of the molecular mechanisms of the onset and progression of chronic pancreatitis.  
Four-week-old male WBN/Kob rats were fed a special breeding diet MB-3 to induce 
chronic pancreatitis. Anti-inflammatory drug such as camostat mesilate (0.01%) and 
Saiko-keishi-to (0.08%) were mixed in the diet MB-3 fed to the rats from 4 weeks. Sections 
were stained with hematoxylin and eosin for histological evaluation. TP53INP1 mRNA 
expression was determined by RT-PCR with a semi-quantitative analysis and in situ 
hybridization. TUNEL was used to detect cell apoptosis. In vitro, 5 mg /ml L-arginine was 
dissolved in the medium of AR4-2J cell. 
TP53INP1 mRNA expression began at 4 weeks, reached its first peak at 12 weeks, after 
decreased at 16 weeks, TP53INP1 mRNA reached its second peak at 20 weeks, finally 
decreased at 24 weeks. By in situ hybridization analysis, TP53INP1 mRNA was strong in the 
acinar cells but absent in duct or islet cells. The apoptotic index was significantly increased at 
12 and 20 weeks showing two peaks, so that, the kinetics of TP53INP1 mRNA expression was 
paralleled to apoptotic index. TP53INP1 mRNA expression was significantly suppressed in the 
camostat mesilate group at 8, 12, and 20 weeks, and it was also significantly suppressed in the 
Saiko-keishi-to treated group at 8 and 12 weeks. TP53INP1 mRNA was expressed in AR4-2J 
cells from 2 to 24 hours. The expression level was significantly higher at 6 hr than those at other 
time points.  
In the present study, TP53INP1 expression showed two peaks in the course of WBN/Kob 
rat. The first peak of TP53INP1 would reflect the concomitant induction of pro-, and 
anti-apoptotic factors at the onset of chronic pancreatitis. Around this time point, the 
histopathology of the pancreas resembles acute edematous pancreatitis, although there is already 
pancreatic fibrosis.  Acinar cell apoptosis would attenuate the severity of pancreatitis, 
preventing the excessive release of harmful pancreatic enzymes. The second peak of acinar cell 
apoptosis and pro-apoptotic factors including TP53INP1 could reflect acinar cell loss and acinar 
remodeling or regeneration during the progression of chronic pancreatitis. Suppression of 
TP53INP1 mRNA expression by therapeutic drugs may confirm that TP53INP1 expression is 
deeply involved in the onset and progression of chronic pancreatitis in this model. 
In conclusion, we have shown that TP53INP1 mRNA expression is induced in the onset 
and progression of chronic pancreatitis in 
WBN/Kob rats. TP53INP1 may be involved 
in the pathogenesis of chronic pancreatitis 
as a pro-apoptotic factor. 
 
Figure: TP53INP1 mRNA was expressed from 4 to 
24 weeks. It showed the first peak at 12 weeks and 
the second peak at 20 weeks.  
